After participating in this webinar, the learner will be able to:

1. Identify the purpose of a QAPI Plan designed for transplant teams.
2. Discuss the relationship between the transplant QAPI Plan and the hospital QAPI Plan
3. Describe key concepts to include in a transplant QAPI Plan
4. Identify resources available to transplant personnel when writing a comprehensive quality plan.

After participating in this webinar, the learner will be able to:

1. Outline elements of a meaningful informed consent process and content elements prescribed by the OPTN.
2. Review psychosocial outcomes and risk factors for poor outcomes (psychological and financial) for transplant recipients and living donors.
3. Describe best practices to promote understanding, including use of teach back, plain language, and culturally relevant approaches.

After participating in this webinar, the learner will be able to:

1. Identify potential benefits and hazards of “grading” living donors for the transplant candidate
2. Understand useful applications and limitations of living donor risk calculators
3. Identify appropriate scenarios in which to consider alternative living donors, with a focus on paired exchange

After participating in this webinar, the learner will be able to:

1. Construct an evidence-based plan for the assessment of cardiovascular risk in the liver transplant candidate
2. Explain the diagnostic criteria for portopulmonary hypertension, treatment strategies to improve liver transplant candidacy and intraoperative management considerations
3. Discuss management approaches for the leading perioperative cardiovascular complications (e.g., atrial fibrillation, congestive heart failure and stroke) in liver transplant recipients

After participating in this webinar, the learner will be able to:

1. Summarize the key pharmacogenomic findings in kidney transplantation.
2. Understand how pharmacogenomics could be used in delivery of transplant care.
3. Outline the limitations of the pharmacogenomic information.

After participating in this webinar, the learner will be able to:

1. Describe appropriate clinical use including and understand the indications and contraindications for use of VV or VA ECMO
2. Understand the hemodynamic effects of ECMO support and impact on left ventricular emptying and its potential for vascular complications
3. Understand the general technology of the ECMO circuit
4. Describe benefits and limitations relative to other forms of temporary mechanical circulatory support

Objectives for the "Non-invasive Biomarkers for Allograft Rejection" webinar include:

1. Discussing the role of Pre-Transplant HLA Molecular Mismatch as a Prognostic Biomarker of Primary Alloimmunity.
2. Discussing the role of Pre-Transplant HLA Molecular Mismatch as a Predictive Biomarker of CNI-based therapy requirements to control Primary Alloimmunity.
3. Discussing the impact of subclinical rejection on longterm survival and the need for non-invasive markers of allograft rejection.
4. Discussing the role of peripheral gene expression for the detection of subclinical rejection.

AST would like to thank the Community of Transplant Scientists (COTS) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending biomarkers for allograft rejection as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.

After participating in this webinar, the learner will be able to:

1. Reviewing the safety and efficacy of hormonal contraceptive options in pediatric and young adult transplant recipients.
2. Summarizing sexually transmitted infection screening, treatment, and management for pediatric and young adult solid organ transplant recipients.
3. Discussing strategies to expand sexual health education for pediatric and young adult solid organ transplant recipients.

After participating in this webinar, the learner will be able to:

1. Discussing and appreciating the changing landscape of liver transplantation for patients with alcohol use disorder (AUD) and alcohol related liver disease (ALD).
2. Describing the diagnosis of AUD and distinguishing the various treatments of AUD and how they work.
3. Recognizing the key management aspects of and role of transplant evaluation in alcohol-related hepatitis from a medical and psychosocial perspective.

Objectives for the "Breaking News in Federal Policy in Organ Transplantation" webinar include:

1. Summarizing current landscape for proposed legislation that impacts OPO performance, organ allocation, and organ transplantation.
2. Reviewing the possible implications of the recent Executive Order on Improving Kidney Care.
3. Exploring critical information to developing strategy and a path forward for an AST position statement.